Rocío Domínguez-Vidaña

The spliceosome is a therapeutic vulnerability in MYC-driven cancer

Tiffany Hsu, Lukas M. Simon, Nicholas J. Neill et al. · Nature · 2015 · 524 citations · Full text

Medicine, Molecular Biology, Oncology +14

A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis

Jessica D. Kessler, Kristopher T. Kahle, Tingting Sun et al. · Science · 2011 · 440 citations

Medicine, Molecular Biology, Oncology +17

Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer

Elizabeth A. Bowling, Jarey H. Wang, Fade Gong et al. · Cell · 2021 · 212 citations · Full text

Medicine, Immunology, Oncology +14

Recurrent DNA inversion rearrangements in the human genome

Margarita Flores, Lucía Morales, Claudia Gonzaga‐Jauregui et al. · Proceedings of the National Academy of Sciences · 2007 · 114 citations

Life Sciences, Genetics, Molecular Genetics +13

Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer

Amritha Nair, Hsiang-Ching Chung, Tingting Sun et al. · Nature Medicine · 2018 · 83 citations

Medicine, Oncology, Pharmacology +12